Vascular events after liver transplantation: A long-term follow-up study

Transplant International

Volumn 21, Issue 1, 2008, Pages 74-80

  Borg, Maarten A J P ^a   Van Der Wouden, Egbert Jan ^a   Sluiter, Wim J ^a   Slooff, Maarten J H ^a   Haagsma, Elizabeth B ^a   Van Den Berg, Arie P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Liver transplantation; Mortality; Risk factors; Survival; Vascular events

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; PREDNISOLONE; TACROLIMUS; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK REDUCTION; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NETHERLANDS; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL RATE; TIME FACTORS;

EID: 36749067337     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00557.x     Document Type: Article

References (30)

1. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002 73 : 901.
2. Neal DA, Tom BD, Luan J, et al. Is there disparity between risk and incidence of cardiovascular disease after liver transplant? Transplantation 2004 77 : 93.
3. Reuben A. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl 2001 7 (Suppl. 1 S13.
4. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998 339 : 229.
5. Abbasoglu O, Levy MF, Brkic BB, et al. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation 1997 64 : 1801.
6. Appleton CP, Hurst RT, Lee KS, et al. Long-term cardiovascular risk in the orthotopic liver transplant population. Liver Transpl 2006 12 : 352.
7. Guckelberger O, Byram A, Klupp J, et al. Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors. Transpl Int 2005 18 : 967.
8. Guckelberger O, Mutzke F, Glanemann M, et al. Validation of cardiovascular risk scores in a liver transplant population. Liver Transpl 2006 12 : 394.
9. Pruthi J, Medkiff KA, Esrason KT, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001 7 : 811.
10. Therapondos G, Flapan AD, Plevris JN, et al. Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl 2004 10 : 1441.
11. Vogt DP, Henderson JM, Carey WD, et al. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002 132 : 775.
12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997 157 : 2413
13. Kuzuya T., Nakagawa S, Satoh J, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002 55 : 65.
14. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005 366 : 1059.
15. Assmann G, Betteridge DJ, Gotto AM, Jr., Steiner G. Management of hypertriglyceridemic patients. A. Treatment classifications and goals. Am J Cardiol 1991 24 : 68.
16. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003 107 : 2185.
17. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999 56 : 2214.
18. Lawes CM, Bennett DA, Lewington S, Rodgers A. Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med 2002 2 : 355.
19. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004 35 : 1024.
20. Asfar S, Metrakos P, Fryer J, et al. An analysis of late deaths after liver transplantation. Transplantation 1996 61 : 1377.
21. Ciccarelli O, Kaczmarek B, Roggen F, et al. Long-term medical complications and quality of life in adult recipients surviving 10 years or more after liver transplantation. Acta Gastroenterol Belg 2005 68 : 323.
22. Lukes DJ, Herlenius G, Rizell M, et al. Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience. Transplant Proc 2006 38 : 2671.
23. Rabkin JM, de La Melena V, Orloff SL, et al. Late mortality after orthotopic liver transplantation. Am J Surg 2001 181 : 475
24. Rea TD., Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002 137 : 494.
25. Alcocer L. Statins for everybody? New evidence on the efficacy and safety of the inhibitors of HMG Co-A reductase. Am J Ther 2003 10 : 423.
26. Gotto AM, Jr. Hypertriglyceridemia: risks and perspectives. Am J Cardiol 1992 70 : 19H.
27. McKenney JM. Pharmacotherapy of dyslipidemia. Cardiovasc Drugs Ther 2001 15 : 413.
28. Levy GA. Long-term immunosuppression and drug interactions. Liver Transpl 2001 7 (Suppl. 1 S53.
29. Munoz SJ, Deems RO, Moritz MJ, Martin P, Jarrell BE, Maddrey WC. Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant Proc 1991 23 : 1480.
30. Romero M, Parera A, Salcedo M, et al. Cardiovascular risk factors and late cardiovascular disease in liver transplantation. Transplant Proc 1999 31 : 2364.